{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HepG2", "Nrf2", "PI3K/AKT", "fucoxanthin", "marine algae", "oxidative stress"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37504922", "DateCompleted": {"Year": "2023", "Month": "07", "Day": "31"}, "DateRevised": {"Year": "2023", "Month": "08", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "03"}], "Language": ["eng"], "ELocationID": ["391", "10.3390/md21070391"], "Journal": {"ISSN": "1660-3397", "JournalIssue": {"Volume": "21", "Issue": "7", "PubDate": {"Year": "2023", "Month": "Jul", "Day": "03"}}, "Title": "Marine drugs", "ISOAbbreviation": "Mar Drugs"}, "ArticleTitle": "Protective Effect of Fucoxanthin on Zearalenone-Induced Hepatic Damage through Nrf2 Mediated by PI3K/AKT Signaling.", "Abstract": {"AbstractText": ["Hepatotoxic contaminants such as zearalenone (ZEA) are widely present in foods. Marine algae have a wide range of potential applications in pharmaceuticals, cosmetics, and food products. Research is ongoing to develop treatments and products based on the compounds found in algae. Fucoxanthin (FXN) is a brown-algae-derived dietary compound that is reported to prevent hepatotoxicity caused by ZEA. This compound has multiple biological functions, including anti-diabetic, anti-obesity, anti-microbial, and anti-cancer properties. Furthermore, FXN is a powerful antioxidant. In this study, we examined the effects of FXN on ZEA-induced stress and inflammation in HepG2 cells. MTT assays, ROS generation assays, Western blots, and apoptosis analysis were used to evaluate the effects of FXN on ZEA-induced HepG2 cell inflammation. Pre-incubation with FXN reduced the cytotoxicity of ZEA toward HepG2 cells. FXN inhibited the ZEA-induced production of pro-inflammatory cytokines, including IL-1 \u03b2, IL-6, and TNF-\u03b1. Moreover, FXN increased HO-1 expression in HepG2 by activating the PI3K/AKT/NRF2 signaling pathway. In conclusion, FXN inhibits ZEA-induced inflammation and oxidative stress in hepatocytes by targeting Nrf2 via activating PI3K/AKT signaling."]}, "AuthorList": [{"Identifier": ["0000-0002-9454-6295"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Center of Biotechnology of Borj-Cedria, Laboratory of Aromatic and Medicinal Plants, Technopole of Borj-Cedria, Hammam-Lif 2050, Tunisia."}], "LastName": "Ben Ammar", "ForeName": "Rebai", "Initials": "R"}, {"Identifier": ["0000-0003-0972-5676"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia."}], "LastName": "Zahra", "ForeName": "Hamad Abu", "Initials": "HA"}, {"Identifier": ["0000-0002-8795-571X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Laboratory Sciences Department, Jordan University of Science and Technology, Irbid 22110, Jordan."}], "LastName": "Abu Zahra", "ForeName": "Abdulmalek Mohammad", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia."}], "LastName": "Alfwuaires", "ForeName": "Manal", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia."}], "LastName": "Abdulaziz Alamer", "ForeName": "Sarah", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Botany and Microbiology Department, Faculty of Science, Assiut University, Assiut 71516, Egypt."}], "LastName": "Metwally", "ForeName": "Ashraf M", "Initials": "AM"}, {"Identifier": ["0000-0002-7025-1847"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomy, College of Veterinary Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia."}], "LastName": "Althnaian", "ForeName": "Thnaian A", "Initials": "TA"}, {"Identifier": ["0000-0002-3171-1855"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomy, College of Veterinary Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia."}], "LastName": "Al-Ramadan", "ForeName": "Saeed Y", "Initials": "SY"}], "GrantList": [{"GrantID": "INST009", "Agency": "Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Mar Drugs", "NlmUniqueID": "101213729", "ISSNLinking": "1660-3397"}, "ChemicalList": [{"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}, {"RegistryNumber": "EC 2.7.1.-", "NameOfSubstance": "Phosphatidylinositol 3-Kinases"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-E2-Related Factor 2"}, {"RegistryNumber": "5W827M159J", "NameOfSubstance": "Zearalenone"}, {"RegistryNumber": "06O0TC0VSM", "NameOfSubstance": "fucoxanthin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylinositol 3-Kinases"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-E2-Related Factor 2"}, {"QualifierName": ["toxicity", "metabolism"], "DescriptorName": "Zearalenone"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": [], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Marin D., Pistol G., Bulgaru C., Taranu I. Cytotoxic and inflammatory effects of individual and combined exposure of HepG2 cells to zearalenone and its metabolites. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 2019;392:937\u2013947. doi: 10.1007/s00210-019-01644-z.", "ArticleIdList": ["10.1007/s00210-019-01644-z", "30919009"]}, {"Citation": "Han X., Huangfu B., Xu T., Xu W., Asakiya C., Huang K., He X. Research progress of safety of zearalenone: A review. Toxins. 2022;14:386. doi: 10.3390/toxins14060386.", "ArticleIdList": ["10.3390/toxins14060386", "PMC9230539", "35737047"]}, {"Citation": "Feng Y.-Q., Zhao A.-H., Wang J.-J., Tian Y., Yan Z.-H., Dri M., Shen W., De Felici M., Li L. Oxidative stress as a plausible mechanism for zearalenone to induce genome toxicity. Gene. 2022;829:146511. doi: 10.1016/j.gene.2022.146511.", "ArticleIdList": ["10.1016/j.gene.2022.146511", "35447234"]}, {"Citation": "Rajendran P., Ammar R.B., Al-Saeedi F.J., Mohamed M.E., ElNaggar M.A., Al-Ramadan S.Y., Bekhet G.M., Soliman A.M. Kaempferol inhibits zearalenone-induced oxidative stress and apoptosis via the PI3K/Akt-mediated Nrf2 signaling pathway: In vitro and in vivo studies. Int. J. Mol. Sci. 2021;22:217. doi: 10.3390/ijms22010217.", "ArticleIdList": ["10.3390/ijms22010217", "PMC7794799", "33379332"]}, {"Citation": "Wu D., Zhong P., Wang Y., Zhang Q., Li J., Liu Z., Ji A., Li Y. Hydrogen sulfide attenuates high-fat diet-induced non-alcoholic fatty liver disease by inhibiting apoptosis and promoting autophagy via reactive oxygen spe-cies/phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling pathway. Front. Pharmacol. 2020;11:585860. doi: 10.3389/fphar.2020.585860.", "ArticleIdList": ["10.3389/fphar.2020.585860", "PMC7774297", "33390956"]}, {"Citation": "Fan W., Lv Y., Ren S., Shao M., Shen T., Huang K., Zhou J., Yan L., Song S. Zearalenone (ZEA)-induced intestinal inflam-mation is mediated by the NLRP3 inflammasome. Chemosphere. 2018;190:272\u2013279. doi: 10.1016/j.chemosphere.2017.09.145.", "ArticleIdList": ["10.1016/j.chemosphere.2017.09.145", "28992480"]}, {"Citation": "Bae M., Kim M.-B., Park Y.-K., Lee J.-Y. Health benefits of fucoxanthin in the prevention of chronic diseases. Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids. 2020;1865:158618. doi: 10.1016/j.bbalip.2020.158618.", "ArticleIdList": ["10.1016/j.bbalip.2020.158618", "31931174"]}, {"Citation": "P\u00e9rez-Torres I., Castrej\u00f3n-T\u00e9llez V., Soto M.E., Rubio-Ruiz M.E., Manzano-Pech L., Guarner-Lans V. Oxidative stress, plant natural antioxidants, and obesity. Int. J. Mol. Sci. 2021;22:1786. doi: 10.3390/ijms22041786.", "ArticleIdList": ["10.3390/ijms22041786", "PMC7916866", "33670130"]}, {"Citation": "Bohn T. Carotenoids and markers of oxidative stress in human observational studies and intervention trials: Implications for chronic diseases. Antioxidants. 2019;8:179. doi: 10.3390/antiox8060179.", "ArticleIdList": ["10.3390/antiox8060179", "PMC6616644", "31213029"]}, {"Citation": "Elvira-Torales L.I., Garc\u00eda-Alonso J., Periago-Cast\u00f3n M.J. Nutritional importance of carotenoids and their effect on liver health: A review. Antioxidants. 2019;8:229. doi: 10.3390/antiox8070229.", "ArticleIdList": ["10.3390/antiox8070229", "PMC6681007", "31330977"]}, {"Citation": "Martin L.J. Fucoxanthin and its metabolite fucoxanthinol in cancer prevention and treatment. Mar. Drugs. 2015;13:4784\u20134798. doi: 10.3390/md13084784.", "ArticleIdList": ["10.3390/md13084784", "PMC4557004", "26264004"]}, {"Citation": "Gen\u00e7 Y., Bardakci H., Y\u00fccel \u00c7., Karatoprak G.\u015e., K\u00fcpeli Akkol E., Hakan Barak T., Sobarzo-S\u00e1nchez E. Oxidative stress and marine carotenoids: Application by using nanoformulations. Mar. Drugs. 2020;18:423. doi: 10.3390/md18080423.", "ArticleIdList": ["10.3390/md18080423", "PMC7459739", "32823595"]}, {"Citation": "Xiao H., Zhao J., Fang C., Cao Q., Xing M., Li X., Hou J., Ji A., Song S. Advances in studies on the pharmacological activities of fucoxanthin. Mar. Drugs. 2020;18:634. doi: 10.3390/md18120634.", "ArticleIdList": ["10.3390/md18120634", "PMC7763821", "33322296"]}, {"Citation": "Ahmed S.A., Mendonca P., Elhag R., Soliman K.F. Anticancer Effects of Fucoxanthin through Cell Cycle Arrest, Apoptosis Induction, Angiogenesis Inhibition, and Autophagy Modulation. Int. J. Mol. Sci. 2022;23:16091. doi: 10.3390/ijms232416091.", "ArticleIdList": ["10.3390/ijms232416091", "PMC9785196", "36555740"]}, {"Citation": "Guan B., Chen K., Tong Z., Chen L., Chen Q., Su J. Advances in fucoxanthin research for the prevention and treatment of inflammation-related diseases. Nutrients. 2022;14:4768. doi: 10.3390/nu14224768.", "ArticleIdList": ["10.3390/nu14224768", "PMC9694790", "36432455"]}, {"Citation": "Mumu M., Das A., Emran T.B., Mitra S., Islam F., Roy A., Karim M.M., Das R., Park M.N., Chandran D. Fucoxanthin: A promising phytochemical on diverse pharmacological targets. Front. Pharmacol. 2022;13:929442. doi: 10.3389/fphar.2022.929442.", "ArticleIdList": ["10.3389/fphar.2022.929442", "PMC9379326", "35983376"]}, {"Citation": "Mohibbullah M., Haque M.N., Sohag A.A.M., Hossain M.T., Zahan M.S., Uddin M.J., Hannan M.A., Moon I.S., Choi J.-S. A systematic review on marine algae-derived fucoxanthin: An update of pharmacological insights. Mar. Drugs. 2022;20:279. doi: 10.3390/md20050279.", "ArticleIdList": ["10.3390/md20050279", "PMC9146768", "35621930"]}, {"Citation": "White M. Master\u2019s Thesis. James Madison University; Harrisonburg, VA, USA: 2021. Fucoxanthin: A Review of Potential Benefits Relative to Human Health."}, {"Citation": "Wang S., Wu S., Yang G., Pan K., Wang L., Hu Z. A review on the progress, challenges and prospects in commercializing microalgal fucoxanthin. Biotechnol. Adv. 2021;53:107865. doi: 10.1016/j.biotechadv.2021.107865.", "ArticleIdList": ["10.1016/j.biotechadv.2021.107865", "34763051"]}, {"Citation": "M\u00e9resse S., Fodil M., Fleury F., Ch\u00e9nais B. Fucoxanthin, a Marine-Derived Carotenoid from Brown Seaweeds and Microalgae: A Promising Bioactive Compound for Cancer Therapy. Int. J. Mol. Sci. 2020;21:9273. doi: 10.3390/ijms21239273.", "ArticleIdList": ["10.3390/ijms21239273", "PMC7730715", "33291743"]}, {"Citation": "Liu M., Li W., Chen Y., Wan X., Wang J. Fucoxanthin: A promising compound for human inflammation-related diseases. Life Sci. 2020;255:117850. doi: 10.1016/j.lfs.2020.117850.", "ArticleIdList": ["10.1016/j.lfs.2020.117850", "32470447"]}, {"Citation": "Pajot A., Hao Huynh G., Picot L., Marchal L., Nicolau E. Fucoxanthin from algae to human, an extraordinary bioresource: Insights and advances in up and downstream processes. Mar. Drugs. 2022;20:222. doi: 10.3390/md20040222.", "ArticleIdList": ["10.3390/md20040222", "PMC9027613", "35447895"]}, {"Citation": "Zheng J., Tian X., Zhang W., Zheng P., Huang F., Ding G., Yang Z. Protective effects of fucoxanthin against alcoholic liver injury by activation of Nrf2-mediated antioxidant defense and inhibition of TLR4-mediated inflammation. Mar. Drugs. 2019;17:552. doi: 10.3390/md17100552.", "ArticleIdList": ["10.3390/md17100552", "PMC6836049", "31569771"]}, {"Citation": "Chen S.-J., Lee C.-J., Lin T.-B., Liu H.-J., Huang S.-Y., Chen J.-Z., Tseng K.-W. Inhibition of ultraviolet B-induced expression of the proinflammatory cytokines TNF-\u03b1 and VEGF in the cornea by fucoxanthin treatment in a rat model. Mar. Drugs. 2016;14:13. doi: 10.3390/md14010013.", "ArticleIdList": ["10.3390/md14010013", "PMC4728510", "26751458"]}, {"Citation": "Mao H., Wang L., Xiong Y., Jiang G., Liu X. Fucoxanthin attenuates oxidative damage by activating the Sirt1/Nrf2/HO-1 signaling pathway to protect the kidney from ischemia-reperfusion injury. Oxidative Med. Cell. Longev. 2022;2022:7444430. doi: 10.1155/2022/7444430.", "ArticleIdList": ["10.1155/2022/7444430", "PMC8816562", "35126819"]}, {"Citation": "Rajendran P., AlZahrani A.M. Fucoxanthin suppresses OxLDL-induced inflammation via activation of Nrf2 and inhibition of NF-\u03baB signaling. Asian Pac. J. Trop. Biomed. 2022;12:207. doi: 10.4103/2221-1691.343388.", "ArticleIdList": ["10.4103/2221-1691.343388"]}, {"Citation": "Wang H., Sun N., Li X., Li K., Tian J., Li J. Diallyl trisulfide induces osteosarcoma cell apoptosis through reactive oxygen species-mediated downregulation of the PI3K/Akt pathway. Oncol. Rep. 2016;35:3648\u20133658. doi: 10.3892/or.2016.4722.", "ArticleIdList": ["10.3892/or.2016.4722", "27035545"]}, {"Citation": "Lin W., Ye H. Anticancer activity of ursolic acid on human ovarian cancer cells via ROS and MMP mediated apoptosis, cell cycle arrest and downregulation of PI3K/AKT pathway. J. BUON. 2020;25:750\u2013756.", "ArticleIdList": ["32521863"]}, {"Citation": "Deng S., Dai G., Chen S., Nie Z., Zhou J., Fang H., Peng H. Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3\u03b2 signaling pathway. Biomed. Pharmacother. 2019;110:602\u2013608. doi: 10.1016/j.biopha.2018.11.103.", "ArticleIdList": ["10.1016/j.biopha.2018.11.103", "30537677"]}, {"Citation": "Zhou S., Sakamoto K. Pyruvic acid/ethyl pyruvate inhibits melanogenesis in B16F10 melanoma cells through PI3K/AKT, GSK3\u03b2, and ROS-ERK signaling pathways. Genes Cells. 2019;24:60\u201369. doi: 10.1111/gtc.12654.", "ArticleIdList": ["10.1111/gtc.12654", "30417494"]}, {"Citation": "Sun X., Chen L., He Z. PI3K/Akt-Nrf2 and anti-inflammation effect of macrolides in chronic obstructive pulmonary disease. Curr. Drug Metab. 2019;20:301\u2013304. doi: 10.2174/1389200220666190227224748.", "ArticleIdList": ["10.2174/1389200220666190227224748", "30827233"]}, {"Citation": "Zhuang Y., Wu H., Wang X., He J., He S., Yin Y. Resveratrol attenuates oxidative stress-induced intestinal barrier injury through PI3K/Akt-mediated Nrf2 signaling pathway. Oxidative Med. Cell. Longev. 2019;2019:7591840. doi: 10.1155/2019/7591840.", "ArticleIdList": ["10.1155/2019/7591840", "PMC6915002", "31885814"]}, {"Citation": "Li J., Wang T., Liu P., Yang F., Wang X., Zheng W., Sun W. Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. Food Funct. 2021;12:3898\u20133918. doi: 10.1039/D0FO02736G.", "ArticleIdList": ["10.1039/D0FO02736G", "33977953"]}, {"Citation": "Dou Y., Huang R., Li Q., Liu Y., Li Y., Chen H., Ai G., Xie J., Zeng H., Chen J., et al. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways. Biomed. Pharmacother. 2021;137:111312. doi: 10.1016/j.biopha.2021.111312.", "ArticleIdList": ["10.1016/j.biopha.2021.111312", "33524788"]}, {"Citation": "Agriopoulou S., Stamatelopoulou E., Varzakas T. Advances in occurrence, importance, and mycotoxin control strategies: Prevention and detoxification in foods. Foods. 2020;9:137. doi: 10.3390/foods9020137.", "ArticleIdList": ["10.3390/foods9020137", "PMC7074356", "32012820"]}, {"Citation": "Gruber-Dorninger C., Jenkins T., Schatzmayr G. Global mycotoxin occurrence in feed: A ten-year survey. Toxins. 2019;11:375. doi: 10.3390/toxins11070375.", "ArticleIdList": ["10.3390/toxins11070375", "PMC6669473", "31252650"]}, {"Citation": "You L., Nepovimova E., Valko M., Wu Q., Kuca K. Mycotoxins and cellular senescence: The impact of oxidative stress, hypoxia, and immunosuppression. Arch. Toxicol. 2023;97:393\u2013404. doi: 10.1007/s00204-022-03423-x.", "ArticleIdList": ["10.1007/s00204-022-03423-x", "36434400"]}, {"Citation": "M\u00e9zes M., Kov\u00e1cs M., Szab\u00f3 A. Toxicology. Elsevier; Amsterdam, The Netherlands: 2021. Mycotoxin exposure, oxidative stress, and lipid peroxidation; pp. 191\u2013200."}, {"Citation": "Al-Jaal B., Latiff A., Salama S., Hussain H.M., Al-Thani N.A., Al-Naimi N., Al-Qasmi N., Horvatovich P., Jaganjac M. Analysis of Multiple Mycotoxins in the Qatari Population and Their Relation to Markers of Oxidative Stress. Toxins. 2021;13:267. doi: 10.3390/toxins13040267.", "ArticleIdList": ["10.3390/toxins13040267", "PMC8068385", "33917988"]}, {"Citation": "Mountford S., Effenberger M., Noll-Puchta H., Griessmair L., Ringleb A., Haas S., Denk G., Reiter F.P., Mayr D., Dinarello C.A. Modulation of liver inflammation and fibrosis by interleukin-37. Front. Immunol. 2021;12:603649. doi: 10.3389/fimmu.2021.603649.", "ArticleIdList": ["10.3389/fimmu.2021.603649", "PMC7970756", "33746950"]}, {"Citation": "Rajendran P., Chen Y.F., Chen Y.F., Chung L.C., Tamilselvi S., Shen C.Y., Day C.H., Chen R.J., Viswanadha V.P., Kuo W.W. The multifaceted link between inflammation and human diseases. J. Cell. Physiol. 2018;233:6458\u20136471. doi: 10.1002/jcp.26479.", "ArticleIdList": ["10.1002/jcp.26479", "29323719"]}, {"Citation": "Del Campo J.A., Gallego P., Grande L. Role of inflammatory response in liver diseases: Therapeutic strategies. World J. Hepatol. 2018;10:1. doi: 10.4254/wjh.v10.i1.1.", "ArticleIdList": ["10.4254/wjh.v10.i1.1", "PMC5787673", "29399273"]}, {"Citation": "Kim Y., Lim H.J., Jang H.-J., Lee S., Jung K., Lee S.W., Lee S.-J., Rho M.-C. Portulaca oleracea extracts and their active compounds ameliorate inflammatory bowel diseases in vitro and in vivo by modulating TNF-\u03b1, IL-6 and IL-1\u03b2 signalling. Food Res. Int. 2018;106:335\u2013343. doi: 10.1016/j.foodres.2017.12.058.", "ArticleIdList": ["10.1016/j.foodres.2017.12.058", "29579933"]}, {"Citation": "Yin H., Huang L., Ouyang T., Chen L. Baicalein improves liver inflammation in diabetic db/db mice by regulating HMGB1/TLR4/NF-\u03baB signaling pathway. Int. Immunopharmacol. 2018;55:55\u201362. doi: 10.1016/j.intimp.2017.12.002.", "ArticleIdList": ["10.1016/j.intimp.2017.12.002", "29223854"]}, {"Citation": "Yang K., Zhan L., Lu T., Zhou C., Chen X., Dong Y., Lv G., Chen S. Dendrobium officinale polysaccharides protected against ethanol-induced acute liver injury in vivo and in vitro via the TLR4/NF-\u03baB signaling pathway. Cytokine. 2020;130:155058. doi: 10.1016/j.cyto.2020.155058.", "ArticleIdList": ["10.1016/j.cyto.2020.155058", "32222695"]}, {"Citation": "Yang Y.-P., Tong Q.-Y., Zheng S.-H., Zhou M.-D., Zeng Y.-M., Zhou T.-T. Anti-inflammatory effect of fucoxanthin on dextran sulfate sodium-induced colitis in mice. Nat. Prod. Res. 2020;34:1791\u20131795. doi: 10.1080/14786419.2018.1528593.", "ArticleIdList": ["10.1080/14786419.2018.1528593", "30488724"]}, {"Citation": "Rajendran P., Nandakumar N., Rengarajan T., Palaniswami R., Gnanadhas E.N., Lakshminarasaiah U., Gopas J., Nishigaki I. Antioxidants and human diseases. Clin. Chim. Acta. 2014;436:332\u2013347. doi: 10.1016/j.cca.2014.06.004.", "ArticleIdList": ["10.1016/j.cca.2014.06.004", "24933428"]}, {"Citation": "Zuo L., Prather E.R., Stetskiv M., Garrison D.E., Meade J.R., Peace T.I., Zhou T. Inflammaging and oxidative stress in human diseases: From molecular mechanisms to novel treatments. Int. J. Mol. Sci. 2019;20:4472. doi: 10.3390/ijms20184472.", "ArticleIdList": ["10.3390/ijms20184472", "PMC6769561", "31510091"]}, {"Citation": "Liguori I., Russo G., Curcio F., Bulli G., Aran L., Della-Morte D., Gargiulo G., Testa G., Cacciatore F., Bonaduce D. Oxidative stress, aging, and diseases. Clin. Interv. Aging. 2018;13:757\u2013772. doi: 10.2147/CIA.S158513.", "ArticleIdList": ["10.2147/CIA.S158513", "PMC5927356", "29731617"]}, {"Citation": "Ezhilarasan D. Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective. Arab. J. Gastroenterol. 2018;19:56\u201364. doi: 10.1016/j.ajg.2018.03.002.", "ArticleIdList": ["10.1016/j.ajg.2018.03.002", "29853428"]}, {"Citation": "Mavrommatis A., Giamouri E., Tavrizelou S., Zacharioudaki M., Danezis G., Simitzis P.E., Zoidis E., Tsiplakou E., Pappas A.C., Georgiou C.A. Impact of mycotoxins on animals\u2019 oxidative status. Antioxidants. 2021;10:214. doi: 10.3390/antiox10020214.", "ArticleIdList": ["10.3390/antiox10020214", "PMC7912820", "33535708"]}, {"Citation": "Badr A.N., Youssef M., Abdel-Razek A.G., Shehata M.G., Hassanien M.M., Amra H. Natural antioxidants: Preservation roles and mycotoxicological safety of food. Egypt. J. Chem. 2021;64:285\u2013298. doi: 10.21608/ejchem.2020.51183.3048.", "ArticleIdList": ["10.21608/ejchem.2020.51183.3048"]}, {"Citation": "Santos E.V., Fontes D.O., Benfato M.d.S., Hackenhaar F.S., Salomon T., Jacob D.V., Pr\u00e9v\u00e9raud D., Araujo W.A.G., da Gl\u00f3ria E.M., Domingos R.L. Mycotoxin deactivator improves performance, antioxidant status, and reduces oxidative stress in nursery pigs fed diets containing mycotoxins. J. Anim. Sci. 2021;99:skab277. doi: 10.1093/jas/skab277.", "ArticleIdList": ["10.1093/jas/skab277", "PMC8525500", "34599328"]}, {"Citation": "Yang Y., Yang I., Cao M., Su Z.-Y., Wu R., Guo Y., Fang M., Kong A.-N. Fucoxanthin elicits epigenetic modifications, Nrf2 activation and blocking transformation in mouse skin JB6 P+ cells. AAPS J. 2018;20:32. doi: 10.1208/s12248-018-0197-6.", "ArticleIdList": ["10.1208/s12248-018-0197-6", "PMC6286093", "29603113"]}, {"Citation": "Ha Y.-J., Choi Y.S., Oh Y.R., Kang E.H., Khang G., Park Y.-B., Lee Y.J. Fucoxanthin suppresses osteoclastogenesis via modulation of MAP kinase and Nrf2 signaling. Mar. Drugs. 2021;19:132. doi: 10.3390/md19030132.", "ArticleIdList": ["10.3390/md19030132", "PMC7997314", "33673704"]}, {"Citation": "Lee N., Youn K., Yoon J.-H., Lee B., Kim D.H., Jun M. The Role of Fucoxanthin as a Potent Nrf2 Activator via Akt/GSK-3\u03b2/Fyn Axis against Amyloid-\u03b2 Peptide-Induced Oxidative Damage. Antioxidants. 2023;12:629. doi: 10.3390/antiox12030629.", "ArticleIdList": ["10.3390/antiox12030629", "PMC10045033", "36978877"]}, {"Citation": "Fang Y., Xing C., Wang X., Cao H., Zhang C., Guo X., Zhuang Y., Hu R., Hu G., Yang F. Activation of the ROS/HO-1/NQO1 signaling pathway contributes to the copper-induced oxidative stress and autophagy in duck renal tubular epithelial cells. Sci. Total Environ. 2021;757:143753. doi: 10.1016/j.scitotenv.2020.143753.", "ArticleIdList": ["10.1016/j.scitotenv.2020.143753", "33316526"]}, {"Citation": "Bekeschus S., Clemen R., Haralambiev L., Niessner F., Grabarczyk P., Weltmann K.-D., Menz J., Stope M., von Woedtke T., Gandhirajan R. The plasma-induced leukemia cell death is dictated by the ROS chemistry and the HO-1/CXCL8 axis. IEEE Trans. Radiat. Plasma Med. Sci. 2020;5:398\u2013411. doi: 10.1109/TRPMS.2020.3020686.", "ArticleIdList": ["10.1109/TRPMS.2020.3020686"]}, {"Citation": "Chiang S.-K., Chen S.-E., Chang L.-C. The role of HO-1 and its crosstalk with oxidative stress in cancer cell survival. Cells. 2021;10:2401. doi: 10.3390/cells10092401.", "ArticleIdList": ["10.3390/cells10092401", "PMC8471703", "34572050"]}, {"Citation": "Niu T., Xuan R., Jiang L., Wu W., Zhen Z., Song Y., Hong L., Zheng K., Zhang J., Xu Q. Astaxanthin induces the Nrf2/HO-1 antioxidant pathway in human umbilical vein endothelial cells by generating trace amounts of ROS. J. Agric. Food Chem. 2018;66:1551\u20131559. doi: 10.1021/acs.jafc.7b05493.", "ArticleIdList": ["10.1021/acs.jafc.7b05493", "29381356"]}, {"Citation": "Yang H.L., Yang T.Y., Gowrisankar Y.V., Liao C.H., Liao J.W., Huang P.J., Hseu Y.C. Suppression of LPS-induced inflammation by chalcone flavokawain a through activation of Nrf2/ARE-mediated antioxidant genes and inhibition of ROS/NF\u03baB signaling pathways in primary splenocytes. Oxidative Med. Cell. Longev. 2020;2020:3476212. doi: 10.1155/2020/3476212.", "ArticleIdList": ["10.1155/2020/3476212", "PMC7306849", "32617135"]}, {"Citation": "Wang H., Ma Z.W., Ho F.M., Sethi G., Tang F.R. Dual Effects of miR-181b-2-3p/SOX21 Interaction on Microglia and Neural Stem Cells after Gamma Irradiation. Cells. 2023;12:649. doi: 10.3390/cells12040649.", "ArticleIdList": ["10.3390/cells12040649", "PMC9954616", "36831315"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "5", "Day": "31"}, {"Year": "2023", "Month": "6", "Day": "26"}, {"Year": "2023", "Month": "6", "Day": "29"}, {"Year": "2023", "Month": "7", "Day": "31", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "7", "Day": "28", "Hour": "13", "Minute": "11"}, {"Year": "2023", "Month": "7", "Day": "28", "Hour": "9", "Minute": "24"}, {"Year": "2023", "Month": "7", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["37504922", "PMC10381773", "10.3390/md21070391", "md21070391"]}}], "PubmedBookArticle": []}